Latest News

Monday, January 21, 2019

New Study Will Evaluate Smart Watch Technology for Help in Preventing Strokes

January 21, 2019 -- A new study will analyze the impact of a smart watch (Apple, Cupertino, CA) on early detection and diagnosis of atrial fibrillation (AFib) and the potential to prevent stroke. The …

Read the full story

Monday, January 21, 2019

FDA Approves Generic Vigabatrin for Complex Partial Seizures

January 21, 2019 -- The Food and Drug Administration (FDA) has approved generic vigabatrin 500 mg tablets for adjunctive treatment of patients with complex partial seizures, age 10 years and older, wh…

Read the full story

Monday, January 21, 2019

Leaky Blood-Brain Barrier May Be Early Biomarker for Cognitive Dysfunction

In a study published in the journal Nature Medicine, researchers showed a correlation between damage of capillaries in the hippocampal region and early cognitive dysfunction, irrespective of…

Read the full story

Friday, January 18, 2019

Valbenazine Reduces Involuntary Movements in Patients with Mood Disorders

A post-hoc analysis of data from a clinical trial of valbenazine (Ingrezza; Neurocrine Biosciences, Inc., San Diego, CA) has been published in the Journal of Affective Disorders. This analysis sh…

Read the full story

Friday, January 18, 2019

FDA Approves Use of Imaging Platform to Select Patients for Clot Removal

The Food and Drug Administration (FDA) has approved a neuroimaging platform (RAPID; iSchemaView, Menlo Park, CA) for selecting stroke patients who are likely to benefit from endovascular thrombectomy.…

Read the full story

Friday, January 18, 2019

Wireless Spinal Cord Stimulator Provides Relief from Chronic Pain

Clinical trial results showed that the world’s first wireless, fully programmable neuromodulation system (Freedom SCS System; Stimwave Technologies, Pompano Beach, FL) provided significant relie…

Read the full story

Thursday, January 17, 2019

First Patient Enrolled in Phase 3 Trial of Low-Dose Formulation of Levetiracetam for Mild Cognitive Impairment

A first patient has been enrolled in a phase 3 clinical trial of a proprietary low-dose formulation of the antiepileptic drug levetiracetam (AGB101; AgeneBio, Baltimore,MD) for the treatment of amnest…

Read the full story

Thursday, January 17, 2019

First Patients Enrolled in Trial of Wearable Neurostimulation Device for Treating Essential Tremor

The Pacific Movement Disorders Center at Pacific Neuroscience Institute announced that the first patients have been enrolled into a trial of a wearable, external, and wireless neuromodulation device (…

Read the full story

Thursday, January 17, 2019

Neuromuscular Community Survey Identifies Key Issues

The Muscular Dystrophy Association (MDA) has announced results of a landmark survey that asked more than 3,000 people affected by neuromuscular disease (NMD) about their key areas of concern and possi…

Read the full story

Wednesday, January 16, 2019

New Drug Application Filed for Lemborexant for Insomnia

A new drug application (NDA) has been filed with the Food and Drug Administration (FDA) for lemborexant (Eisei, Woodcliff Lake, NJ and Purdue Pharma, Stamford, CT). Lemborexant is a small molecule und…

Read the full story

Wednesday, January 16, 2019

Registry for Peripheral Nerve Stimulation for Pain Management Is Launched

The first registry related to peripheral nerve stimulation (PNS) for pain management is enrolling patients. The registry will collect long-term clinical data with the goal of educating physicians on h…

Read the full story

Thursday, January 10, 2019

Eye-Movement Tracker Approved for Diagnosing Concussion

The Food and Drug Administration has granted a de novo request for marketing authorization of an algorithm-driven eye-movement tracking system (Eyebox; Oculogica, New York, NY) for the diagnosis of co…

Read the full story

Wednesday, January 09, 2019

Breakthrough Device Designation Granted to Brain-Monitoring Technology

The Food and Drug Administration has granted breakthrough device designation to a brain health monitoring technology (Neurametrix; San Francisco, CA). The approved use is monitoring Parkinson’s …

Read the full story

Tuesday, January 08, 2019

Federal Supply Schedule Adds External Vagus Nerve Stimulator for Headache Prevention and Treatment

A noninvasive vagus nerve stimulation (nVNS) device (gammaCore; electroCore, Basking Ridge, NJU) has been award a 5-year Federal Supply Schedule medical equipment and supply contract that makes the de…

Read the full story

Tuesday, January 08, 2019

Phase 3 Trial of Dioscorea japonica Extracts To Be Initiated for Treatment of Pain From Diabetic Neuropathy

The planned initiation of a phase 3 double-blind, placebo controlled, 12-week study of Dioscorea japonica extracts (NB-01; Neurobo, Boston, MA) for pain relief in patients with diabetic neur…

Read the full story
Load More